Wilson Sonsini Goodrich & Rosati is pleased to sponsor LaunchBio’s Larger Than Life Science Series: Funding Now! The Investor Pulse: The impact of COVID 19 on Biotech Investor Strategies. Recently in the news, there have been announcements of life science venture funds raising over $100M. While this is excellent news for the funds, what does this mean for companies looking to raise capital? What will the future hold in funding start-ups? How has COVID-19 impacted investors' mandates, and what changes are coming to the industry? A panel of investors will provide insight into these topics and let start-ups know what they can do to raise capital.
Lori Doyle
ldoyle@wsgr.com